This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade and was followed in 2013 by From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade.

Corporate author(s): Policy Cures, PATH, Medicines for Malaria Venture, Innovative Vector Control Consortium, Foundation for Innovative New Diagnostics, Roll Back Malaria Partnership

Publication date: June 2011

Available materials


Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA